BXP

BEXIMCO PHARMACEUTICALS LIMITED GDR (EACH REPR 1 ORD BDT10)

TitleTime
World?s first generic remdesivir for COVID-19Thu 21/05/20 | 07:00
COVID-19 UpdateMon 04/05/20 | 07:00
Beximco announces Commercial Agreement with MylanMon 24/02/20 | 07:00
Half Year Results 2019-20Wed 29/01/20 | 07:00
Payment of Cash DividendMon 20/01/20 | 11:06
AGM StatementMon 23/12/19 | 10:46
AGM NotificationTue 19/11/19 | 08:57
Results for First Quarter Ended 30 September 2019Thu 14/11/19 | 07:00
Results for the 12 month period ended 30 June 2019Mon 11/11/19 | 07:00
Notification of Preliminary Results and AGMTue 29/10/19 | 07:00
Update on Dividend and Tax legislation changesThu 08/08/19 | 09:18
Beximco launches fifth product in the US marketTue 30/07/19 | 07:00
Dividend and Tax changes for Bangladesh companiesThu 18/07/19 | 16:01
3rd Quarter ResultsMon 29/04/19 | 07:00
Beximco receives FDA approval for CyproheptadineWed 24/04/19 | 07:00
Beximco Pharma to Acquire Eight ANDAs from SandozWed 20/02/19 | 07:00
Appointment of BrokerMon 04/02/19 | 11:32
Half Year Results 2018-19Thu 31/01/19 | 07:00
Payment of Cash DividendTue 22/01/19 | 07:00
EGM StatementThu 27/12/18 | 07:00
AGM StatementThu 27/12/18 | 07:00
EGM NotificationFri 30/11/18 | 07:00
AGM NotificationFri 30/11/18 | 07:00
Results for First Quarter Ended 30 September 2018Wed 14/11/18 | 07:00
Results for the 12 month period ended 30 June 2018Wed 07/11/18 | 07:00
Notification of Preliminary Results and AGMFri 26/10/18 | 07:00
US FDA Approves Beximco Pharma's Nadolol TabletsMon 30/07/18 | 07:00
Commences export of fourth product to the USMon 23/07/18 | 07:00
3rd Quarter ResultsFri 27/04/18 | 07:00
Commences Export of Third Product to the US MarketMon 23/04/18 | 07:00
Completion of the Acquisition of Nuvista PharmaTue 03/04/18 | 07:00
Half Year Results 2017-18Tue 30/01/18 | 07:00
Acquisition of a Majority Stake in Nuvista PharmaFri 19/01/18 | 07:00
Payment of Cash DividendFri 19/01/18 | 07:00
AGM StatementWed 27/12/17 | 07:00
Notice of AGMThu 23/11/17 | 11:53
Results for First Quarter Ended 30 September 2017Tue 14/11/17 | 07:00
Commencement of Second Product Export to the USTue 07/11/17 | 07:00
Results for the 12 month period ended 30 June 2017Mon 06/11/17 | 10:30
Notice of Preliminary Results and AGMThu 26/10/17 | 07:00
Signs a Non-Binding MoU with Nuvista PharmaFri 06/10/17 | 07:00
Change of BrokerMon 02/10/17 | 07:00
Commences Export to CanadaMon 18/09/17 | 07:00
FDA approves Beximco Pharma Methocarbamol tabletsTue 25/07/17 | 07:00